Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Alterity Therapeutics Investor Presentation

April 10, 2019 Kerry Rowe

Alterity Therapeutics Investor Presentation 10 April 2019

Post navigation

Alterity Therapeutics Launches to Asian Investors

Alterity Therapeutics presents at the American Academy of Neurology Annual Meeting

Related Posts

Prana Announces that New York Academy of Sciences eBriefing available online

July 17, 2013

Prana’s Founding Scientist and CSA publishes landmark paper in Nature

October 12, 2014

Prana Maintains NASDAQ Listing

April 11, 2016

Recent Posts

Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study
Alterity completes Placement Tranche 1 raising $10M
Alterity raises $35M in placement to international and Australian institutions and sophisticated investors.
XBRL 30 June 2020 filed with the SEC
New data independently confirms and extends laboratory findings and expands safety profile of ATH434

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065